Department of Pediatrics and The Tulane Hypertension and Renal Center of Excellence, Tulane University School of Medicine, SL-37, 1430 Tulane Avenue, New Orleans, LA, 70112, USA.
Clin Exp Nephrol. 2021 Mar;25(3):215-223. doi: 10.1007/s10157-020-01995-5. Epub 2021 Jan 4.
Histone deacetylases (HDACs) are important epigenetic regulators that mediate deacetylation of both histone and non-histone proteins. HDACs, especially class I HDACs, are highly expressed in developing kidney and subject to developmental control. HDACs play an important role in kidney formation, especial nephron progenitor maintenance and differentiation. Several lines of evidence support the critical role of HDACs in the development and progression of various kidney diseases. HDAC inhibitors (HDACis) are very effective in the prevention and treatment of kidney diseases (including kidney cancer). A better understanting of the molecular mechanisms underlying the role(s) of HDACs in the pathogenesis and progression of renal disease are likely to be of great help in developing more effective and less toxic selective HDAC inhibitors and combinatorial therapeutics.
组蛋白去乙酰化酶(HDACs)是重要的表观遗传调控因子,可介导组蛋白和非组蛋白的去乙酰化。HDACs,尤其是 I 类 HDACs,在发育中的肾脏中高度表达,并受到发育调控。HDACs 在肾脏形成中发挥重要作用,特别是肾祖细胞的维持和分化。有几条证据表明 HDACs 在各种肾脏疾病的发生和进展中起关键作用。HDAC 抑制剂(HDACi)在预防和治疗肾脏疾病(包括肾癌)方面非常有效。更好地了解 HDACs 在肾脏疾病发病机制和进展中的作用的分子机制,可能有助于开发更有效、毒性更小的选择性 HDAC 抑制剂和联合治疗药物。